Create a free account
Join Calaméo to publish and share documents with the world!
Rate and comment your favorite publications, download documents and share your readings with your friends.
The Future of Blood Disorders Therapeutics Analysis and Market Forecasts to 2016
3 pages
Published by
rgunnam
The Future of Blood Disorders Therapeutics, Analysis and Market
Forecasts to 2016 - Better and More Cost-Effective Treatment Options
Create Opportunities
The Global Blood Disorders Market is Forecast to Show Moderate Growth Due to a...
[More]
The Future of Blood Disorders Therapeutics, Analysis and Market
Forecasts to 2016 - Better and More Cost-Effective Treatment Options
Create Opportunities
The Global Blood Disorders Market is Forecast to Show Moderate Growth Due to a
Series of Patent Expiries
In 2009, the global blood disorders market was estimated to be worth $38.
4 billion,
representing a cumulative annual growth rate (CAGR) of 7.
7% between 2001 and 2009.
By 2016, the global blood disorders market is expected to reach $50.
8 billion, indicating
a CAGR of 4.
1% between 2009 and 2016.
The major reason behind the decline in the
growth rate is the decline in the annual cost of treating blood disorders after 2011.
The global blood disorders market is expected to witness a series of patent expiries
between 2009 and 2016, which includes most of the top selling blockbuster drugs in the
anemia, thrombosis, hemophilia and neutropenia market.
The major drugs that are set
to lose patent protection between 2009 and 2016 are N
[Less]
Tags
analysis,
blood,
companies,
cost,
current,
disorders,
drugs,
expected,
forecasts,
future,
global,
growth,
market,
patent,
players,
report
